SURPASS-CVOT is a phase 3 study enrolled approximately 13,000 patients at least 40 years of age and have a diagnosis of type 2 diabetes, confirmed atherosclerotic cardiovascular disease, HbA1c 7.0% to 10.5% and a body mass index (BMI) 25 kilograms per meter squared (kg/m 2 )
What happens if you take Imodium for too long
Healthcare Systems and Providers: As referenced above, health systems will need to understand how a reduction in certain diseases and a healthier population will impact the demand for different services, and how they need to adapt their service configuration to meet evolving population needs
Agents in this class are approved for treatment of type 2 diabetes and reduction of cardiovascular disease, as well as weight management
NNC0165-1875 has recently completed a phase 2 trial in combination with semaglutide 2.4 mg once weekly (NCT04969939), but results are not currently available
Regina DePietro, MD, a family medicine physician at MU Health Care in Columbia, Missouri, says that people also may microdose GLP-1s if they only want to lose a small amount of weight
